Infertility DNA repair Gene expression Advanced maternal age Transcriptomics Cumulus cells
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women diagnosed with infertility who are undergoing treatment with in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). 2. Women receiving ovarian stimulation using a GnRH antagonist protocol, including stimulation with recombinant follicle-stimulating hormone (recombinant FSH), prevention of premature ovulation with a GnRH antagonist, and final oocyte maturation triggered by a dual-trigger approach using a GnRH agonist and recombinant human chorionic gonadotropin (hCG).
Exclusion criteria
Exclusion criteria: 1. Women diagnosed with conditions that may affect gene expression, such as endometriosis, polycystic ovary syndrome (PCOS), or endocrine disorders (e.g., diabetes mellitus). 2. Women with a body mass index (BMI) more than 30 kg/m2. 3. Women with a history of ovarian surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DNA repair gene expression in Cumulus cell of MII oocytes between younger and older patients 12 months DNA repair gene expression was assessed by RNA sequencing to identify differentially expressed genes between two groups, and results were validated using RT-qPCR. | — |
Secondary
| Measure | Time frame |
|---|---|
| Age-related alterations in DNA repair pathways for evaluating ovarian aging. 12 months To investigate which DNA repair mechanisms are primarily associated with age-related changes in order to explain oocyte aging.,Oocyte quality, such as fertilization and blastocyst development. 12 months To investigate the association between DNA repair gene expression and oocyte quality, such as fertilization and blastocyst development (in percentage ) | — |
Countries
Thailand
Contacts
Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University